Menu
CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

William Newton, Associate Editor/Senior Writer Views
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.